載入...

Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine‐1‐phosphate receptor modulator

AIMS: Fingolimod is a sphingosine‐1‐phosphate (S1P) receptor modulator approved for the treatment of the relapsing form of multiple sclerosis (MS). It prevents the egress of lymphocyte subpopulations from lymphoid tissues into the circulation. Here, we explored the broad effects of fingolimod on gen...

全面介紹

Na minha lista:
書目詳細資料
發表在:CNS Neurosci Ther
Main Authors: Angerer, Ines C., Hecker, Michael, Koczan, Dirk, Roch, Luisa, Friess, Jörg, Rüge, Annelen, Fitzner, Brit, Boxberger, Nina, Schröder, Ina, Flechtner, Kristin, Thiesen, Hans‐Jürgen, Winkelmann, Alexander, Meister, Stefanie, Zettl, Uwe K.
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490155/
https://ncbi.nlm.nih.gov/pubmed/29314605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12793
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!